title: Vestibular rehabilitation with virtual reality in Ménière's disease.
abstract: Virtual reality technology can provide a wide range of sensory stimuli to generate conflicts of varying degrees of complexity in a safe environment.
  
  
  OBJECTIVE
  To verify the effect of a virtual realitybased balance rehabilitation program for patients with Menière's disease.
  
  
  METHODS
  This observational clinical study included 44 patients aged between 18 and 60 years diagnosed with Menière's disease submitted to a controlled randomized therapeutic intervention. The case and control groups took betahistine and followed a diet. Case group subjects underwent 12 rehabilitation sessions with virtual reality stimuli in a Balance Rehabilitation Unit (BRU TM). Patients were assessed based on DHI scores, the dizziness visual analogue scale, and underwent posturography with virtual reality before and after the intervention.
  
  
  RESULTS
  After the intervention, the case group showed significantly lower scores in DHI (p < 0,001) and in the dizziness visual analog scale (p = 0.012), and had significantly greater limit of stability areas (p = 0.016) than controls.
  
  
  CONCLUSIONS
  Virtual reality-based balance rehabilitation effectively improved dizziness, quality of life, and limit of stability of patients with Menière's disease.
authors.affiliation: Federal University of São Paulo, Paulista Medical School (UNIFESP-EPM), Brazil.
authors.forename: Adriana Pontin
authors.initials: AP
authors.lastname: Garcia
authors.forename: Mauricio Malavasi
authors.initials: MM
authors.lastname: Ganança
authors.forename: Flávia Salvaterra
authors.initials: FS
authors.lastname: Cusin
authors.forename: Andreza
authors.initials: A
authors.lastname: Tomaz
authors.forename: Fernando Freitas
authors.initials: FF
authors.lastname: Ganança
authors.forename: Heloisa Helena
authors.initials: HH
authors.lastname: Caovilla
mesh_terms: D000328:Adult; D001621:Betahistine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D017442:Histamine Agonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008575:Meniere Disease / Q000188:drug therapy* / Q000534:rehabilitation*; D008875:Middle Aged; D004856:Postural Balance; D016896:Treatment Outcome; D014724:Vestibular Function Tests; D063367:Virtual Reality Exposure Therapy / Q000379:methods*; D055815:Young Adult
chemical_list: D017442:Histamine Agonists; D001621:Betahistine